Multiple myeloma in adolescents and young adults(AYA): global epidemiological trends, risk factors, and future projections (1990–2040)
Menée à partir des données 2021 de l'étude "the Global Burden of Disease", cette étude analyse, sur la période 1990-2021, l'évolution de l'incidence du myélome multiple et de la mortalité chez les adolescents et jeunes adultes (âge : 15-39 ans) puis livre des projections jusqu'en 2040
Introduction: Multiple myeloma (MM) is a hematological malignancy with increasing incidence among adolescents and young adults (AYAs) aged 15 to 39 years. This trend presents unique challenges related to long-term treatment effects, fertility, and late-onset complications. Risk factors include obesity, diabetes, environmental exposures, and genetic predispositions, with a higher incidence observed in males and individuals of African-American descent. This study aims to analyze global trends in MM incidence and mortality among AYAs from 1990 to 2021 and project future trends through 2040.
Methods: Using data from the Global Burden of Disease (GBD) 2021 study, we analyzed the age-specific incidence rate (IR), and death rate (DR) per 100,000 patient-years of AYA MM. Statistical modeling, including two sample t-test were done to estimate the standard deviations among each group, which is plugged into the denominator to compute the statistic. Auto-Regressive Integrated Moving Average (ARIMA) and Exponential Smoothing State Space (ETS) models were applied for projections.
Results: In 2021, the global AYA MM incidence was 2536 cases (IR 0.09/100,000 patient-years), and deaths totaled 1579 (DR 0.05/100,000 patient-years). From 1990 to 2021, IR and DR increased (annual percentage change (APC) of 0.84 for IR and 0.60 for DR). Males exhibited higher rates and faster increases. High-middle SDI regions had the highest IR and DR, with Mauritius recording the highest national rates. High BMI contributed to 6.52% of MM-related deaths in 2021. Projections indicate rising IR and DR globally through 2040.
Conclusion: The increasing burden of AYA MM necessitates early detection, targeted treatments, and preventive measures addressing obesity and other modifiable risk factors. Reducing regional disparities through improved healthcare access is essential to mitigate the growing impact of MM.
Cancer Causes & Control , résumé, 2026